Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Haploidentical Transplantation with Post-Transplant Cyclophosphamide Versus Single Cord Blood Transplantation for Adults with Relapsed/Refractory Malignant Lymphoma

Masashi Nishikubo, Yoshimitsu Shimomura, Yosuke Nakaya, Akihito Shinohara, Naoyuki Uchida, Nobuyuki Takayama, Hikaru Kobayashi, Yasufumi Uehara, Jun Ishikawa, Kazuya Ishiwata, Nobuhiro Hiramoto, Hideyuki Nakazawa, Fumihiko Ishimaru, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Eisei Kondo, Shinichi Kako

Blood (2023) 142 (Supplement 1): 3607.

https://doi.org/10.1182/blood-2023-178951

Published: 2023

Journal Articles

Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 899.

https://doi.org/10.1182/blood-2023-184709

Published: 2023

Journal Articles

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Blood (2022) 140 (Supplement 1): 6690–6692.

https://doi.org/10.1182/blood-2022-157438

Published: 2022

Journal Articles

Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Kimimori Kamijo, Yoshimitsu Shimomura, Sung-Won Kim, Takahide Ara, Jun Ishikawa, Tetsuya Eto, Nobuhiro Hiramoto, Ishikazu Mizuno, Shigeru Kusumoto, Yasunori Ueda, Ken-ichi Matsuoka, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Eisei Kondo

Blood (2022) 140 (Supplement 1): 2393–2394.

https://doi.org/10.1182/blood-2022-159411

Published: 2022

Journal Articles

Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT

Yoshinobu Maeda, MD PhD, Tomotaka Ugai, MD, Eisei Kondo, Kazuhiro Ikegame, MD PhD, Makoto Murata, MD PhD, Naoyuki Uchida, MD PhD, Toshihiro Miyamoto, MD PhD, Satoshi Takahashi, MD PhD, Kazuteru Ohashi, MD PhD, Hirohisa Nakamae, MD PhD, Makoto Hirokawa, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD, Junya Kanda, MD

Blood (2018) 132 (Supplement 1): 4635.

https://doi.org/10.1182/blood-2018-99-112796

Published: 2018

Journal Articles

Impact of Incomplete Blood Count Recovery Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Engraftment and Early Infection in Patients with Acute Myeloid Leukemia

Takeru Asano, MD, Shuntaro Ikegawa, MD, Tomoko Inomata, MD, Naoto Ikeda, MD, Hiroyuki Sugiura, MD, Taiga Kuroi, MD, Shohei Yoshida, MD, Hisakazu Nishimori, MD PhD, Ken-ichi Matsuoka, MD PhD, Nobuharu Fujii, MD PhD, Eisei Kondo, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 3408.

https://doi.org/10.1182/blood.V128.22.3408.3408

Published: 2016

Journal Articles

Successful Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mild Renal Dysfunction Calculated By Creatinin Clearance

Shuntaro Ikegawa, MD, Tomoko Inomata, MD, Naoto Ikeda, MD, Hiroyuki Sugiura, MD, Taiga Kuroi, MD, Takeru Asano, MD, Shohei Yoshida, MD, Hisakazu Nishimori, MD PhD, Ken-ichi Matsuoka, MD PhD, Nobuharu Fujii, MD PhD, Eisei Kondo, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 4656.

https://doi.org/10.1182/blood.V128.22.4656.4656

Published: 2016

Journal Articles

Anti-IL-12/23 p40 Antibody Attenuates Chronic Graft Versus Host Disease Via Suppression of IFN-γ/IL-17-Producing Cells

Taiga Kuroi, MD, Sachiyo Okamoto, MD, Kyosuke Saeki, MD, Yujin Kobayashi, MD, Hisakazu Nishimori, MD PhD, Hideaki Fujiwara, Ken-ichi Matsuoka, Nobuharu Fujii, MD PhD, Eisei Kondo, Mitsune Tanimoto, MD PhD, Yoshinobu Maeda, MD PhD

Blood (2014) 124 (21): 1095.

https://doi.org/10.1182/blood.V124.21.1095.1095

Published: 2014

Journal Articles

Use of Recombinant Thrombomodulin for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation Ameliorate Disease Severity

Hideaki Fujiwara, Yoshinobu Maeda, MD PhD, Yasuhisa Sando, Makoto Nakamura, Katsuma Tani, Takanori Ishikawa, Hisakazu Nishimori, MD PhD, Ken-Ichi Matsuoka, MDPhD, Nobuharu Fujii, MD PhD, Eisei Kondo, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2014) 124 (21): 1141.

https://doi.org/10.1182/blood.V124.21.1141.1141

Published: 2014

Journal Articles

Outcome of Pediatric-Type Therapy for Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA): A Study by the Japan Adult Leukemia Study Group (JALSG ALL202-U study)

Toru Sakura, MD, PhD, Fumihiko Hayakawa, MD, PhD, Toshiaki Yujiri, MD, Yasutaka Aoyama, MD, Eisei Kondo, MD, Katsumichi Fujimaki, MD, Yasunori Ueda, MD, PhD, Shigeki Ohtake, MD, PhD, Yasushi Miyazaki, MD, PhD, Shuichi Miyawaki, MD, PhD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2012) 120 (21): 1464.

https://doi.org/10.1182/blood.V120.21.1464.1464

Published: 2012

Journal Articles

Prevention of Idiopathic Pneumonia Syndrome by Intra-Bone Marrow Injection of Donor Cells

Yoshiko Yamasuji, Hisakazu Nishimori, Haruko Sugiyama, Koichiro Kobayashi, Sachiyo Okamoto, Eisei Kondo, Nobuharu Fujii, Katsuji Shinagawa, Takuro Kanekura, Mitsune Tanimoto, Yoshinobu Maeda

Blood (2011) 118 (21): 1902.

https://doi.org/10.1182/blood.V118.21.1902.1902

Published: 2011

Journal Articles

Synthetic Retinoid Am80 Ameliorates Chronic Graft-Versus-Host Disease.

Hisakazu Nishimori, MD, Haruko Sugiyama, MD, Koichiro Kobayashi, MD, Yoshiko Yamasuji, MD, Eisei Kondo, MD, PhD, Katsuji Shinagawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kengo Takeuchi, MD, PhD, Yoshinobu Maeda, MD, PhD

Blood (2009) 114 (22): 4487.

https://doi.org/10.1182/blood.V114.22.4487.4487

Published: 2009

Journal Articles

Activated human B cells: stimulatory or tolerogenic antigen-presenting cells?

Alexander Shimabukuro-Vornhagen, Eisei Kondo, Tanja Liebig, Michael von Bergwelt-Baildon

Blood (2009) 114 (3): 746–747.

https://doi.org/10.1182/blood-2009-03-212886

Published: 2009

Journal Articles

Early Kinetics of Engraftment Following Reduced-Intensity Stem Cell Transplantation: Fludarabine and Cyclophosphamide Versus Fludarabine and Busulfan.

Teruhiko Kozuka, MD, Fumihiko Ishimaru, MD, Keitaro Matsuo, MD, Hiromi Nakashima, Nobuharu Fujii, MD, Kenichi Matsuoka, MD, Eisei Kondo, MD, Yoshio Katayama, MD, Yoshinobu Maeda, MD, Katsuji Shinagawa, MD, Kazuma Ikeda, MD, Mitsune Tanimoto, MD

Blood (2006) 108 (11): 2957.

https://doi.org/10.1182/blood.V108.11.2957.2957

Published: 2006

Journal Articles

Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles

Eisei Kondo, Yoshiki Akatsuka, Kiyotaka Kuzushima, Kunio Tsujimura, Shoji Asakura, Kohei Tajima, Yoshitoyo Kagami, Yoshihisa Kodera, Mitsune Tanimoto, Yasuo Morishima, Toshitada Takahashi

Blood (2004) 103 (2): 630–638.

https://doi.org/10.1182/blood-2003-03-0824

Published: 2004

NARROW

Haploidentical Transplantation with Post-Transplant Cyclophosphamide Versus Single Cord Blood Transplantation for Adults with Relapsed/Refractory Malignant Lymphoma

Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT

Impact of Incomplete Blood Count Recovery Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Engraftment and Early Infection in Patients with Acute Myeloid Leukemia

Successful Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mild Renal Dysfunction Calculated By Creatinin Clearance

Anti-IL-12/23 p40 Antibody Attenuates Chronic Graft Versus Host Disease Via Suppression of IFN-γ/IL-17-Producing Cells

Use of Recombinant Thrombomodulin for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation Ameliorate Disease Severity

Outcome of Pediatric-Type Therapy for Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA): A Study by the Japan Adult Leukemia Study Group (JALSG ALL202-U study)

Prevention of Idiopathic Pneumonia Syndrome by Intra-Bone Marrow Injection of Donor Cells

Synthetic Retinoid Am80 Ameliorates Chronic Graft-Versus-Host Disease.

Activated human B cells: stimulatory or tolerogenic antigen-presenting cells?

Early Kinetics of Engraftment Following Reduced-Intensity Stem Cell Transplantation: Fludarabine and Cyclophosphamide Versus Fludarabine and Busulfan.

Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only